Dr. Ni Lin, Managing Director of SDIC (State Development and Investment Corporation), has more than 20 years of industry experience in the life sciences field; such as new drug research scientist, multinational company manager and venture capitalist.

Prior to joining SDIC, she was the Managing Director of 6 Dimensions Capital. She was also the director of WuXi AppTec’s strategic investment department managing corporate strategic M&A and venture capital funds. She has led and participated in more than 20 investments in the life sciences and medical fields in China and in the United States, of which nearly half have been exited.

Prior to becoming a VC, she was the senior manager of Pfizer’s business development department, responsible for Pfizer’s R&D cooperation and expansion in Japan, and supporting Pfizer’s animal health division’s product launch, cooperation, strategic investment and M&A in the Asia Pacific region. Dr. Ni started her career at Bayer’s new drug development center in Kyoto. She has a bachelor’s degree in biology from East China Normal University, and a master’s and doctorate degree in pharmacy from Osaka University in Japan.